V024-4275 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

V024-4275 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide
V024-4275 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-4275
N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-4275

Molecular Formula

C34H48N4O5S (C34 H48 N4 O5 S)

Compound Name

N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-N-(2-{[5-(3-methoxyphenyl)-134-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

SMILES

CCCCCCCCCCCC(N(CCC(Nc1nnc(-c2cc(OC)ccc2)s1)=O)CCc(cc1)cc(OC)c1OC)=O

InChI

InChI=1S/C34H48N4O5S/c1-5-6-7-8-9-10-11-12-13-17-32(40)38(22-20-26-18-19-29(42-3)30(24-26)43-4)23-21-31(39)35-34-37-36-33(44-34)27-15-14-16-28(25-27)41-2/h14-16,18-19,24-25H,5-13,17,20-23H2,1-4H3,(H,35,37,39)

InChI Key

DZSMIFLFHSWRIF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19714630

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

624.85

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

23.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

7.699

Distribution Coefficient, logD

7.699

Water Solubility, LogSw

-5.69

Polar Surface Area

85.106

Acid Dissociation Constant (pKa)

10.55

Base Dissociation Constant (pKb)

-0.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.90

V024-4275 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Lipid Metabolism Library (9174 compounds)

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V024-4275 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-4275?
Check Price and Availability of V024-4275, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-4275 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-4275
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-4275
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-4275 available by request